Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia

The American Journal of Pathology
J L HoltonT Revesz


Familial British dementia (FBD), pathologically characterized by cerebral amyloid angiopathy (CAA), amyloid plaques, and neurofibrillary degeneration, is associated with a stop codon mutation in the BRI gene resulting in the production of an amyloidogenic fragment, amyloid-Bri (ABri). The aim of this study was to assess the distribution of ABri fibrillar and nonfibrillar lesions and their relationship to neurofibrillary pathology, astroglial and microglial response using immunohistochemistry, confocal microscopy, and immunoelectron microscopy in five cases of FBD. Abnormal tau was studied with immunoblotting. We present evidence that ABri is deposited throughout the central nervous system in blood vessels and parenchyma where both amyloid (fibrillar) and pre-amyloid (nonfibrillar) lesions are formed. Ultrastructurally amyloid lesions appear as bundles of fibrils recognized by an antibody raised against ABri, whereas Thioflavin S-negative diffuse deposits consist of amorphous electron-dense material with sparse, dispersed fibrils. In contrast to nonfibrillar lesions, fibrillar ABri is associated with a marked astrocytic and microglial response. Neurofibrillary tangles and neuropil threads occurring mainly in limbic structures, a...Continue Reading


Jan 1, 1991·Acta Neuropathologica·H Braak, E Braak
Jun 1, 1990·Brain : a Journal of Neurology·G PlantP C Gautier-Smith
Jan 1, 1985·Experimental Brain Research·H BjörklundL Olson
Jul 1, 1985·Annals of Neurology·F GrayR Escourolle
Mar 1, 1982·Journal of Neurology, Neurosurgery, and Psychiatry·S Love, L W Duchen
May 1, 1982·Journal of Neurology, Neurosurgery, and Psychiatry·R A GriffithsJ M Spalding
Jan 4, 1993·Neuroscience Letters·R DayN G Seidah
Jun 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·Michel GoedertV M Lee
Oct 24, 1998·Trends in Neurosciences·M G Spillantini, Michel Goedert
Nov 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·M E CalhounMathias Jucker
Apr 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·R VidalB Frangione
Jul 1, 1933·The Journal of Neurology and Psychopathology·C Worster-DroughtW H McMenemey


Nov 10, 2009·Cellular and Molecular Life Sciences : CMLS·A RostagnoJ Ghiso
Mar 14, 2009·Acta Neuropathologica·Claudia SchwabPatrick L McGeer
May 18, 2010·Acta Neuropathologica·Lilla ReinigerSebastian Brandner
Feb 23, 2011·Acta Neuropathologica·Tammaryn LashleyTamas Revesz
Sep 26, 2009·Brain Structure & Function·Holly J GarringerR Vidal
Sep 14, 2011·Neurotoxicity Research·Russell H Swerdlow
Oct 24, 2003·Brain Research. Brain Research Reviews·Annemieke A M RensinkMarcel M Verbeek
Mar 10, 2005·Experimental Neurology·James W Geddes
Oct 30, 2003·Journal of Molecular Biology·Rekha SrinivasanMichael G Zagorski
Nov 28, 2002·Advanced Drug Delivery Reviews·J Ghiso, B Frangione
Feb 5, 2003·Neuroscience Letters·Fiona PickfordEileen McGowan
Jul 15, 2011·Brain : a Journal of Neurology·Tammaryn LashleyTamas Revesz
Dec 14, 2002·Annals of the New York Academy of Sciences·Youngah ShinSteven M Greenberg
May 24, 2012·Journal of Biomedicine & Biotechnology·Monica VitaleNicola Zambrano
Nov 20, 2009·PloS One·Luca GilibertoLuciano D'Adamio
Nov 5, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Robert TamayevLuciano D'Adamio
Apr 20, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Robert Tamayev, Luciano D'Adamio
Dec 30, 2015·Acta Neuropathologica·Seth Love, J Scott Miners
Dec 17, 2008·Biotechnology Journal·Maria TsachakiSpiros Efthimiopoulos
Dec 17, 2014·Neuropathology and Applied Neurobiology·Gabor G Kovacs
Sep 25, 2003·Neurological Research·Roy O Weller, James A Nicoll
Sep 7, 2013·Diagnostic and Interventional Imaging·C QuachJ P Cottier
Dec 24, 2004·Biochimica Et Biophysica Acta·Nicolas SergeantLuc Buée
Feb 16, 2005·Annual Review of Physiology·Michael F Beers, Surafel Mulugeta
Jul 6, 2016·Brain Pathology·Gabor G KovacsBeata Sikorska
Sep 13, 2016·Brain Research Bulletin·Thomas ArendtMax Holzer
Jan 24, 2017·The International Journal of Neuroscience·Neha SamiMd Imtaiyaz Hassan
Sep 24, 2005·Dementia and Geriatric Cognitive Disorders·Jack van HorssenPieter Wesseling
Jan 8, 2017·Cold Spring Harbor Perspectives in Biology·Brittany N Dugger, Dennis W Dickson
Nov 6, 2017·Journal of Alzheimer's Disease : JAD·Elena TamagnoMassimo Tabaton
Sep 23, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Tamas Revesz, J L Holton
Apr 15, 2006·Brain Pathology·Fiona PickfordEileen McGowan

Related Concepts

Related Feeds

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Microglia

Microglia are a type of glial cell found throughout the brain and spinal cord. Microglia have been found to be associated with Alzheimer's disease development and progression. Here are the latest discoveries pertaining to Alzheimer's disease and microglia.


Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Astrocytes & Amyloid

Astrocytes are thought to play a role in amyloid production and have been implicated in neurodegenerative diseases such as Alzheimer’s disease. Here is the latest research on the relationship between astrocytes and amyloid.